Showing results (41-50 of 188) with videos related to

Sort By:
Pageof 19
Molecular and Cellular Probes|February 21, 2006
Spectral and photobleaching analysis using confocal laser scanning microscopy: a comparison of modern and archaeological bone fluorescenceCorey Maggiano, Tosha Dupras, Michael Schultz, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 14, 2020
Evaluation of lactulose, lactose, and fructose breath testing in clinical practice: A focus on methaneRuth M Harvie, Caroline J Tuck, Michael Schultz
The Anatomical Record. Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology|November 4, 2004
Histological structure of antlers in castrated male fallow deer (Dama dama)Uwe Kierdorf, Horst Kierdorf, Michael Schultz, et al.
Community Health Equity Research & Policy|March 10, 2026
Medication Adherence Support in Aotearoa New Zealand: No Central Policy, No Ownership, No AccountabilityObreniokibo Ibifubara Amiesimaka, Kristina Aluzaite, Michael Schultz, et al.
The New Zealand Medical Journal|January 23, 2024
Using electronic health records in analysing medication adherence in southern New Zealand patients with inflammatory bowel diseasesObreniokibo I Amiesimaka, Kristina Aluzaite, Rhiannon Braund, et al.
The New Zealand Medical Journal|July 28, 2023
Constraints on medication-based inflammatory bowel disease therapy in Aotearoa New Zealand-why medication adherence is importantObreniokibo I Amiesimaka, Rhiannon Braund, Kristina Aluzaite, et al.
Patient Preference and Adherence|April 25, 2024
Improving Medication Adherence Levels in Inflammatory Bowel Disease (IBD) Patients: A Narrative Evidence-Based ReviewObreniokibo Ibifubara Amiesimaka, Kristina Aluzaite, Rhiannon Braund, et al.
Journal of Gastroenterology and Hepatology|December 28, 2019
Infliximab trough levels: A comparison between the Quantum Blue Infliximab assay and the established ELISAMing Han Lim, Kristina Aluzaite, Michael Schultz, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|November 29, 2018
Is non-alcoholic fatty liver disease a reflection of what we eat or simply how much we eat?Kiri P H Sharp, Michael Schultz, Kirsten J Coppell
Exploratory Research in Clinical and Social Pharmacy|December 26, 2023
"It's just like putting your socks on": patients' perspectives on inflammatory bowel disease medication adherenceObreniokibo Ibifubara Amiesimaka, Kristina Aluzaite, Rhiannon Braund, et al.
Pageof 19